What will the future of vaccines look like? Will we need an annual booster shot? Could the science behind the coronavirus help treat other diseases like cancer?
L.A. Times columnist Anita Chabria spoke with Dr. Vivek Naranbhai with the Dana-Farver Cancer Institutes and the Massachusetts General Hospital Cancer Center and Dr. Peter Hotez, the Dean at the National School of Tropical Medicine at Baylor College of Medicine in Houston, to break it down for us.
A few disclosures: Dr. Patrick Soon-Shiong, the chairman of the Los Angeles Times, is CEO of the biotech company ImmunityBio, which is manufacturing a COVID vaccine created by Dr. Hotez and his team.
SUBSCRIBE FOR MORE VIDEOS AND NEWS
http://www.youtube.com/subscription_center?add_user=losangelestimes
https://www.latimes.com/subscription
LET’S CONNECT:
Facebook ► https://www.facebook.com/latimes
Twitter ► https://twitter.com/LATimes
Instagram ► https://www.instagram.com/latimes
L.A. Times columnist Anita Chabria spoke with Dr. Vivek Naranbhai with the Dana-Farver Cancer Institutes and the Massachusetts General Hospital Cancer Center and Dr. Peter Hotez, the Dean at the National School of Tropical Medicine at Baylor College of Medicine in Houston, to break it down for us.
A few disclosures: Dr. Patrick Soon-Shiong, the chairman of the Los Angeles Times, is CEO of the biotech company ImmunityBio, which is manufacturing a COVID vaccine created by Dr. Hotez and his team.
SUBSCRIBE FOR MORE VIDEOS AND NEWS
http://www.youtube.com/subscription_center?add_user=losangelestimes
https://www.latimes.com/subscription
LET’S CONNECT:
Facebook ► https://www.facebook.com/latimes
Twitter ► https://twitter.com/LATimes
Instagram ► https://www.instagram.com/latimes
- Category
- U.S. & Canada
- Tags
- Los Angeles Times, LA Times, L. A. Times
Sign in or sign up to post comments.
Be the first to comment